Formulary Chapter 2: Cardiovascular system - Full Chapter
|
02.02.03 |
Potassium-sparing diuretics and aldosterone antagonists |
|
|
02.02.03 |
Aldosterone antagonists |
|
|
Eplerenone
|
Second Choice

|
Tablet
SECOND CHOICE
Second line aldosterone antagonist if spironolactone is not tolerated for NYHA class II heart failure
Second Line agent if Spironolactone is not tolerated for use within the licenced indication, of stable post MI patient with left ventricular dysfunction and clinical evidence of heart failure in line with NICE guidance.
|
Key |
|
|
Cytotoxic Drug
|
|
Controlled Drug
|
|
High Cost Medicine
|
|
Cancer Drugs Fund
|
|
NHS England |
|
Homecare |
|
CCG |
|
Traffic Light Status Information
|
|